These miRNAs affect cardiac hypertrophy by targeting the anti‐hypertrophic and proautophagic transcription factor forkhead box O3 (FoxO3), leading to induction of the prohypertrophic calcineurin/NFAT signalling pathway 121. This evidence concerns the gene FOXO3 and cardiac hypertrophy.